GB201414910D0 - Composition - Google Patents

Composition

Info

Publication number
GB201414910D0
GB201414910D0 GBGB1414910.8A GB201414910A GB201414910D0 GB 201414910 D0 GB201414910 D0 GB 201414910D0 GB 201414910 A GB201414910 A GB 201414910A GB 201414910 D0 GB201414910 D0 GB 201414910D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1414910.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mars Inc
Original Assignee
Mars Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mars Inc filed Critical Mars Inc
Publication of GB201414910D0 publication Critical patent/GB201414910D0/en
Priority to CN201580026829.1A priority Critical patent/CN106413743A/zh
Priority to PCT/EP2015/061327 priority patent/WO2015177309A1/en
Priority to CA2945049A priority patent/CA2945049A1/en
Priority to EP15726899.6A priority patent/EP3145535A1/en
Priority to RU2016150516A priority patent/RU2733403C2/ru
Priority to AU2015261792A priority patent/AU2015261792A1/en
Priority to US15/313,516 priority patent/US20170196927A1/en
Priority to JP2016562228A priority patent/JP2017516757A/ja
Priority to JP2020094125A priority patent/JP2020147582A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
GBGB1414910.8A 2014-05-23 2014-08-21 Composition Ceased GB201414910D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CN201580026829.1A CN106413743A (zh) 2014-05-23 2015-05-21 用于关节炎、可动性和延缓衰老的组合物
PCT/EP2015/061327 WO2015177309A1 (en) 2014-05-23 2015-05-21 Composition for arthritis, mobility and delay ageing
CA2945049A CA2945049A1 (en) 2014-05-23 2015-05-21 Composition for arthritis, mobility and delay ageing
EP15726899.6A EP3145535A1 (en) 2014-05-23 2015-05-21 Composition for arthritis, mobility and delay ageing
RU2016150516A RU2733403C2 (ru) 2014-05-23 2015-05-21 Композиция для лечения артрита, поддержания подвижности и замедления старения
AU2015261792A AU2015261792A1 (en) 2014-05-23 2015-05-21 Composition for arthritis, mobility and delay ageing
US15/313,516 US20170196927A1 (en) 2014-05-23 2015-05-21 Composition for arthritis, mobility and delay ageing
JP2016562228A JP2017516757A (ja) 2014-05-23 2015-05-21 関節炎、運動性および老化の遅延のための組成物
JP2020094125A JP2020147582A (ja) 2014-05-23 2020-05-29 関節炎、運動性および老化の遅延のための組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14305772 2014-05-23

Publications (1)

Publication Number Publication Date
GB201414910D0 true GB201414910D0 (en) 2014-10-08

Family

ID=50928040

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1414910.8A Ceased GB201414910D0 (en) 2014-05-23 2014-08-21 Composition

Country Status (9)

Country Link
US (1) US20170196927A1 (https=)
EP (1) EP3145535A1 (https=)
JP (2) JP2017516757A (https=)
CN (1) CN106413743A (https=)
AU (1) AU2015261792A1 (https=)
CA (1) CA2945049A1 (https=)
GB (1) GB201414910D0 (https=)
RU (1) RU2733403C2 (https=)
WO (1) WO2015177309A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2657434C2 (ru) 2013-05-14 2018-06-13 Марс, Инкорпорейтед Композиция для ухода за суставом
JP2018100238A (ja) * 2016-12-21 2018-06-28 花王株式会社 歩行機能改善剤
US11110147B2 (en) 2017-03-15 2021-09-07 Rousselot B.V Collagen hydrolysates as a beneficial prebiotic and their effect on joint inflammation and osteoarthritis
BE1027357B1 (nl) * 2019-06-12 2021-01-18 Vanlommel Maria Kristel Voedingssupplement voor versnelde genezing

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425487D0 (en) * 1994-12-16 1995-02-15 Res Inst Osteoarthritis treatment
CA2336602C (en) * 1998-07-07 2010-11-02 Coastside Bio Resources Companion animal therapeutic treat
US7544772B2 (en) * 2001-06-26 2009-06-09 Biomarck Pharmaceuticals, Ltd. Methods for regulating inflammatory mediators and peptides useful therein
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
KR20020011594A (ko) * 2000-08-03 2002-02-09 박종성 콘드로이친, 글루코사민, 신선초분말 등의 기능성소재가함유된 캅셀식품 및 그 제조방법
US20060029647A1 (en) * 2004-02-09 2006-02-09 Friesen Kim G Composition and method for use in cartilage affecting conditions
US20050181047A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
US20060062859A1 (en) * 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
AU2006248645A1 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
AU2006249771A1 (en) * 2005-05-24 2006-11-30 Wellgen, Inc. Compositions and methods for the prevention and treatment of conditions associated with inflammation
WO2008154178A1 (en) * 2007-06-06 2008-12-18 Novus International Inc. Dietary supplements for promotion of growth, repair, and maintenance of bone and joints
EP2106798A1 (en) * 2008-04-02 2009-10-07 Nestec S.A. Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair
US8937194B2 (en) * 2008-12-31 2015-01-20 Nitromega Corp. Topical compositions containing nitro fatty acids
JP5324000B1 (ja) * 2012-03-08 2013-10-23 サントリーホールディングス株式会社 イミダゾールペプチドとケルセチン配糖体を含有する組成物
CN103143002B (zh) * 2013-03-29 2014-12-03 武汉中博绿亚生物科技有限公司 一种用于宠物骨关节的保健剂及其制备方法

Also Published As

Publication number Publication date
JP2020147582A (ja) 2020-09-17
RU2016150516A3 (https=) 2018-11-13
RU2016150516A (ru) 2018-06-26
CN106413743A (zh) 2017-02-15
JP2017516757A (ja) 2017-06-22
WO2015177309A1 (en) 2015-11-26
CA2945049A1 (en) 2015-11-26
RU2733403C2 (ru) 2020-10-01
EP3145535A1 (en) 2017-03-29
AU2015261792A1 (en) 2016-11-03
US20170196927A1 (en) 2017-07-13

Similar Documents

Publication Publication Date Title
GB201410905D0 (en) Composition
GB201501859D0 (en) Composition
SG11201704735WA (en) Composition
GB201403017D0 (en) Composition
GB201504665D0 (en) Composition
ZA201704464B (en) Composition
GB201408167D0 (en) Compositions
IL251479A0 (en) components
GB201505520D0 (en) Composition
GB201414910D0 (en) Composition
GB201403561D0 (en) Composition
PL3217964T3 (pl) Kompozycja
GB201414555D0 (en) Composition
GB201410493D0 (en) Composition
SG11201610547WA (en) Solid composition
GB201404700D0 (en) Novel Composition
GB201519442D0 (en) Composition
GB201404390D0 (en) Composition
ZA201606127B (en) Composition
GB201420628D0 (en) Composition
GB201415483D0 (en) Composition
GB201402648D0 (en) Composition
IL250781A0 (en) preparation
GB201503484D0 (en) Composition
GB201502355D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)